The S&P 500, a Better-Than-Expected Inflation Report, and the Biggest Short Squeeze in Market History
In an especially volatile year, the S&P 500 (Index: SPX) continues to provide excitement! The index closed the trading week at 3,992.93, ending Friday, 11 November 2022 up 222.38 points (+5.9%) from the close of the previous trading week.
Getting there involved the thirteenth Lévy flight event of 2022 by our rough count, prompted by a better-than-expected Consumer Price Inflation report, and fueled by what ZeroHedge described as the “biggest short-squeeze on record, based on Goldman’s ‘Most Shorted’ basket”.
For the dividend futures-based model‘s alternative futures chart, we see the new Lévy flight event as a shift in the forward-looking time horizon for investors from 2023-Q1 back toward the current quarter of 2022-Q4.
That shift occurred because with inflation being reported lower than expected, the message the Federal Reserve’s interest-rate setting Federal Open Market Committee will send at its upcoming 13-14 December 2022 meetings will carry especial weight for what investors should expect going into 2023.
Going back to the alternative futures chart, we see the level of the S&P 500 is elevated with respect to the trajectory for investors focusing their attention on 2022-Q4. It’s running at the high end of the range the model projects over the next several weeks, which may be the result of noise from the short-squeeze rally.
Given that investors are focusing on 2022-Q4, we need to point out there will be at least one more Lévy flight event before the end of 2022. If that happens during the next several weeks, that means stock prices would fall by a significant percentage. There’s also the wild card factor of the additional noise that has been injected into the market from the short squeeze event. Noise always dissipates, it’s only ever a question of when. In this case, that dissipation will also mean falling stock prices.
Here’s a recap of the week’s market moving headlines:
- Monday, 7 November 2022
-
- Signs and portents for the U.S. economy:
- Fed minions say they’re strangling economy even harder than data says:
- Bigger stimulus developing in China:
- Bigger trouble developing everywhere:
- Weakening global demand hurts Vietnam’s garment makers – industry official
- Euro zone grapples with coordinating energy support plans as recession looms
- Germany told to pay for Eurozone energy crisis:
- Central bank minions stuck on rate hikes:
- ECB minions thought about it, can’t stop, won’t stop rate hikes as they prep for Eurozone recession:
- ECB must not stop rate hikes before core inflation peak, Villeroy says
- ECB scrutinises banks’ payout plans as outlook sours
- U.S. stocks end higher, Meta jumps as investors eye midterms
- Tuesday, 8 November 2022
-
- Signs and portents for the U.S. economy:
- Oil prices slide $2 on China demand worries, U.S. midterm elections
- Consumers turn to credit cards, loans as costs soar – report
- BOJ minions briefly consider ending never-ending stimulus, JapanGov minions okay more fiscal stimulus:
- Japan’s cabinet OKs extra budget spending, adding to debt
- ECB minions excited about hiking rates, embrace their “dark side” as they deal with developing cracks in financial system:
- ECB to continue raising rates even as economy suffers
- ECB supervisors show dark side of higher rates for banks
- EU eases bank capital rules as ECB warns of ‘cracking’ stability
- Euro zone bonds wobble as central banks zero in on inflation
- Wall Street ends higher as investors eye U.S. midterms
- Wednesday, 9 November 2022
-
- Signs and portents for the U.S. economy:
- Oil prices plunge 3% on U.S. inventory build, China COVID worries
- U.S. wholesale inventories revised lower in September
- Potentially divided U.S. government tees up tough economic debates for 2023
- Fed minions admitting rate hikes will cause recession, markets betting Federal Funds Rate will top out at 5%:
- Barkin: U.S. likely on “back end” of inflation surge
- Fed’s Williams flags relative stability of longer run inflation expectations
- Fed terminal rate to reach just under 5%, said bond strategists – Reuters poll
- Bigger trouble developing in China:
- China’s Oct new yuan loans seen sliding as demand weakens – Reuters poll
- China’s factory gate prices suffer first drop since Dec 2020 as COVID curbs take toll
- ECB minions say higher inflation is still coming to Eurozone despite their rate hikes:
- Wall Street drops after midterm election, CPI in focus
- Thursday, 10 November 2022
-
- Signs and portents for the U.S. economy:
- U.S. inflation turning the corner as consumer prices rise below expectations
- Oil prices settle 1% higher on tepid U.S. inflation data
- Fed seen slowing rate hike pace as inflation eases
- Fed’s George calls for ‘more measured’ pace of rate hikes
- Fed’s Daly: would rather do too much on rates than too little
- Fed’s Mester cheered by CPI, but says big risks remain on inflation
- Fed’s Harker says time coming where Fed can slow rate hikes
- Fed’s Logan: Inflation data a ‘welcome relief,’ still long way to go
- Bigger trouble developing in China:
- China new bank lending stumbles as COVID flare-ups hit demand
- China year-end export bounce in doubt as global demand falters
- Central banks thinking they can should start backing off rate hikes:
- BOJ minions thinking about ending never-ending stimulus:
- ECB minions want more rate hikes, starting to worry about Eurozone bank’s potentially failing:
- ECB’s Nagel calls for letting long-term rates rise too
- ECB’s Schnabel flags inflation risk from wages, expectations
- ECB’s Enria calls time on era of big bank buybacks
- ECB to lend out more of its bonds to ease market squeeze
- Wall Street soars on sign of cooling inflation
- Friday, 11 November 2022
-
- Signs and portents for the U.S. economy:
- Oil settles higher, posts weekly loss as China eases COVID curbs
- U.S. consumer sentiment slumps; inflation expectations edge up
- Fed minion says more rake hikes coming despite worry about overtightening sending economy into recession:
- Bigger trouble developing in the Eurozone:
- Euro zone bond market flashes recession signal
- Energy crisis dims festive sparkle in Europe’s shops
- German harmonised inflation +11.6% y/y in October
- Bigger trouble developing in China:
- No easy fix for China as economy slows more than expected
- Hong Kong’s economy shrinks for third straight quarter, outlook dims
- BOJ, JapanGov minions thinking about ending never-ending stimulus in face of inflation:
- BOJ must phase out yield cap, negative rate – govt panel member Okina
- Japan Oct consumer inflation likely to hit four-decade high – Reuters poll
- Japan’s Oct wholesale prices rise 9.1% yr/yr
- Inflation brings end to beloved 114-year-old Japanese candy
- ECB minions thinking next rate hike may be smaller, Eurozone inflation may be higher:
- ECB not pre-committed to raise rates by 75 bps again, De Cos says
- ECB’s de Guindos says market might be underestimating inflation
- ECB’s Holzmann says he doesn’t know how he’ll vote at December meeting
- Nasdaq, S&P 500 end sharply higher, fueled by inflation optimism
With the lower-than-expected Consumer Price Inflation report, the CME Group’s FedWatch Tool still has a half point rate hike on tap for 14 December (2022-Q4). But in 2023, the FedWatch tool now projects two quarter point rate hikes, in February and March (2023-Q1), with the Federal Funds Rate reaching a peak target range of 4.75-5.00%. Looking further forward, the FedWatch tool anticipates two quarter point rate cuts in 2023-Q4 (November and December) as developing recessionary conditions take hold in the U.S. economy.
Meanwhile, the Atlanta Fed’s GDPNow tool‘s projection for real GDP growth in 2022-Q4 rose to +4.0% from last week’s +3.6% estimate. There continues to be a big gap between its current projection and the so-called “Blue Chip consensus” that anticipates near zero growth in 2022-Q4.
Source: https://politicalcalculations.blogspot.com/2022/11/the-s-500-better-than-expected.html
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.